Goodwin advised River on the funding round. River closed its $40 million Series B led by Yamaha Motor Co., Ltd. The round also saw participation from existing...
River’s $40 Million Series B Funding Round
Heart Aerospace’s $107 Million Series B Funding Round
Goodwin advised Heart Aerospace in the round. DLA Piper advised EQT Ventures on the deal. Swedish hybrid-electric airplane maker Heart Aerospace raised a total of $107...
Miro’s Acquisition of Freehand
Goodwin advised Miro in its acquisition of Freehand. Miro has acquired the visual collaboration platform, Freehand, from InVision. The deal includes the technology and brand assets, customer...
Sonic Healthcare’s $150 Million Acquisition of Pathology Watch
Goodwin advised Pathology Watch on the sale to Sonic Healthcare. Sonic Healthcare acquired Utah-based medical-tech provider Pathology Watch for US$150 million in what the Australian company...
Novo Nordisk’s $1.3 Billion Acquisition of Ocedurenone
KBP Biosciences was represented by Goodwin Procter LLP and Novo Nordisk was represented by Covington & Burling LLP in this transaction. Novo Nordisk A/S and KBP...
Kyowa Kirin’s $387 Million Acquisition of Orchard Therapeutics
Kyowa Kirin was represented by Goldman Sachs Japan Co., Ltd. as financial advisor and Morrison & Foerster LLP. as legal advisor. Orchard Therapeutics was represented by...
Aman’s $360 Million Funding Round
Goodwin advised Alpha Wave Global on the investment. Alpha Wave Global, alongside Mubadala Capital, invested in Aman Group’s $360 million funding round. The investment values Aman, run...
Mariana Oncology’s $175 Million Series B Financing Round
Goodwin advised Mariana Oncology on the fundraising. Mariana Oncology Inc. announced its oversubscribed $175 million Series B financing co-led by Deep Track Capital and Forbion, and...
Bregal Sagemount’s Strategic Growth Investment in Bradford Airport Logistics
Goodwin Procter and Allen & Overy advised Sagemount, while Sidley advised Bradford Airport Logistics on the deal. Bradford Airport Logistics announced that it received a significant growth...
Revolution Medicines’ Acquisition of EQRx
Latham & Watkins advises Revolution Medicines on the deal, and Goodwin Procter advises EQRx. Revolution Medicines, Inc. (Nasdaq: RVMD) and EQRx, Inc. (Nasdaq: EQRX) announced a definitive agreement...
K36 Therapeutics’ $70 Million Series B Financing Round
Goodwin advised K36 Therapeutics on the financing. K36 Therapeutics announced a $70M Series B financing. The round was led by Nextech Invest, Ltd, a precision medicine focused...
C4 Therapeutics’ Exclusive Licensing Agreement with Betta Pharmaceuticals
Goodwin Procter served as legal counsel to C4T, and Han Kun Law Offices served as legal counsel to Betta. C4 Therapeutics, Inc. announced its exclusive licensing agreement...